Repurposing anthelmintic agents to eradicate resistant leukemia

Despite rapid progress in genomic profiling in acute lymphoblastic leukemia (ALL), identification of actionable targets and prediction of response to drugs remains challenging. To identify specific vulnerabilities in ALL, we performed a drug screen using primary human ALL samples cultured in a model...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezzatesta, Caterina, Abduli, Liridon, Guinot, Anna, Eckert, Cornelia, Schewe, Denis, Zaliova, Marketa, Vinti, Luciana, Marovca, Blerim, Tsai, Yi-Chien, Jenni, Silvia, Aguade-Gorgorio, Julia, von Stackelberg, Arend, Schrappe, Martin, Locatelli, Franco, Stanulla, Martin, Cario, Gunnar, Bourquin, Jean-Pierre, Bornhauser, Beat C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320149/
https://www.ncbi.nlm.nih.gov/pubmed/32591499
http://dx.doi.org/10.1038/s41408-020-0339-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320149/
https://www.ncbi.nlm.nih.gov/pubmed/32591499
http://dx.doi.org/10.1038/s41408-020-0339-9

Ejemplares similares